BioMed Research International

BioMed Research International / 2014 / Article
Special Issue

New Advances in Reproductive Biomedicine

View this Special Issue

Research Article | Open Access

Volume 2014 |Article ID 673537 | 7 pages | https://doi.org/10.1155/2014/673537

Good Preservation of Stromal Cells and No Apoptosis in Human Ovarian Tissue after Vitrification

Academic Editor: Irma Virant-Klun
Received30 Jan 2014
Accepted14 Mar 2014
Published03 Apr 2014

Abstract

The aim of this study was to develop a vitrification procedure for human ovarian tissue cryopreservation in order to better preserve the ovarian tissue. Large size samples of ovarian tissue retrieved from 15 female-to-male transgender subjects (18–38 years) were vitrified using two solutions (containing propylene glycol, ethylene glycol, and sucrose at different concentrations) in an open system. Light microscopy, transmission electron microscopy, and TUNEL assay were applied to evaluate the efficiency of the vitrification protocol. After vitrification/warming, light microscopy showed oocyte nucleus with slightly thickened chromatin and irregular shape, while granulosa and stromal cells appeared well preserved. Transmission electron microscopy showed oocytes with slightly irregular nuclear shape and finely dispersed chromatin. Clear vacuoles and alterations in cellular organelles were seen in the oocyte cytoplasm. Stromal cells had a moderately dispersed chromatin and homogeneous cytoplasm with slight vacuolization. TUNEL assay revealed the lack of apoptosis induction by vitrification in all ovarian cell types. In conclusion after vitrification/warming the stromal compartment maintained morphological and ultrastructural features similar to fresh tissue, while the oocyte cytoplasm was slightly damaged. Although these data are encouraging, further studies are necessary and essential to optimize vitrification procedure.

1. Introduction

Ovarian tissue cryopreservation and its storage offer the hope to prepubertal girls or fertile age women who suffer from benign or malignant disease and want to safeguard their ovarian function against the hazardous effects of surgery, chemotherapy, and radiotherapy.

Despite the encouraging results much can still be done to minimize tissue damage during the cryopreservation procedure. It is known that the cryopreservation procedure leads to a loss in the follicular pool when compared with fresh ovarian tissue [1]. This result is principally due to ice crystal formation during the cryopreservation procedures, which can have a deleterious effect on cellular interactions and cell membranes [2].

Cryopreservation of ovarian tissue is primarily performed by slow freezing/rapid thawing for human fertility preservation and 24 live births and 4 ongoing pregnancies have been obtained after transplantation with this technique [3]. However, many studies have emphasized that the slow freezing of ovarian tissue safeguards the smallest follicles in the tissue, while it determined the greatest damage in the stroma cells [4, 5].

An emerging alternative procedure for the cryopreservation of ovarian tissue is represented by vitrification/warming. The vitrification is an ultrarapid cooling process that produces a glass-like solidification of cells by extreme elevation in viscosity, so as to avoid cellular injury caused by ice crystal formation [610]. In order to achieve successful vitrification, high cooling rates, as well as high concentrations of cryoprotectants are required.

This method has been successfully applied to preserve human blastocyst and oocyte [11, 12]. For ovarian tissue, good results have been reported in rodents, domestic animals, nonhuman primates, and human; even if, data on human ovarian tissue vitrification are still limited [13].

The aim of this study was to develop a vitrification procedure for human ovarian tissue cryopreservation in order to better preserve the ovarian tissue.

2. Materials and Methods

2.1. Patients

The study was conducted in 15 female-to-male transgender subjects (FTMs), 18–38 years, (, mean age ± standard deviation) suffering from gender identity disorder and undergoing sex reassignment surgery by hysterectomy-ovariectomy (Clinical trial n°61/2007/O/Tess) at Gynecology and Pathophysiology of Human Reproduction Unit, University of Bologna, Italy. The patients have donated their ovarian tissue for research. For each patient ovarian tissue samples were analyzed at the time of sample collection (fresh tissue, t0) and after vitrification/warming (vitrified/warmed tissue, t1). t1 sample was compared with t0 sample of the same patient to minimize the interpatient variation.

2.2. Tissue Sampling

For each patient, a bioptic ovarian sample was collected at the time of surgery and immediately transferred to the laboratory in a Dulbecco’s phosphate buffered solution (PBS) (Gibco, Life Technologies LTD, Paisley, Scotland) with 10% inactivated human serum (provided by the Transfusion Centre of S.Orsola-Malpighi Hospital of Bologna, Italy). Bioptic ovarian sample was cut into slices 1,5 × 0,5 × 0,2 cm with a scalpel blade, placed in precooled plastic cryovials (Intermed Nunc Cryotubes, Roskilde, Denmark) and cryopreserved using the vitrification/warming protocol. For each patient, three samples (3 mm2) were processed for light microscopy, transmission electron microscopy, and TUNEL assay (fresh tissue, t0).

2.3. Vitrification/Warming Protocol
2.3.1. Vitrification Protocol

The vitrification protocol was based on a two-step method in an open carrier. Each ovarian sample was placed in a cryovial containing 1.8 mL of equilibration solution consisting of 2 M propylene glycol (Fluka Chemical, Sigma Aldrich, SrL, Milan, Italy) + 3 M ethylene glycol (Fluka Chemical, Sigma Aldrich, SrL, Milan, Italy) + 0.2 M sucrose (Fluka Chemical, Sigma Aldrich, SrL, Milan, Italy) + 15% human serum in PBS and was transferred to a rolling system at 4°C for 30 min. Subsequently, the sample was transferred into a second cryovial containing 1.8 mL of vitrification solution consisting of 3 M propylene glycol + 5 M ethylene glycol + 0.5 M sucrose + 15% human serum in PBS and newly put onto a rolling system at 4°C for 30 min. Then, the sample was loaded in 200 μL of vitrification solution on an open plastic support and quickly immersed into liquid nitrogen decontaminated according to Parmegiani protocol [14]. Following, the support containing the sample was placed in an empty cryovial (Intermed Nunc Cryotubes, Denmark) and stored into a liquid nitrogen tank for at least 1-2 months before warming.

2.3.2. Warming Protocol

The support containing the sample was released from the cryovial, exposed at room temperature for 30 sec, and then immersed in a warming solution consisting of 1 M sucrose + 15% human serum in PBS at 39°C for 1 min, gently shaking until the ice was completely melted. Subsequently, the cryoprotectant was removed at 4°C by stepwise dilution of sucrose. The sample was transferred to the solution 1 (0.5 M sucrose + PBS + 15% human serum) for 3 min, and then to the solution 2 (0.25 M sucrose + 15% human serum in PBS) for 3 min. Finally, the warmed sample was rinsed in preequilibrated α minimal essential medium (α-MEM, Sigma Aldrich SrL; Milan, Italy) supplemented with penicillin/streptomycin (0.1 mg/mL) + 10% human serum two times at 4°C for 1 min. For each patient, warmed sample was fixed for the same analysis conducted on fresh sample (warmed tissue, t1).

2.4. Light and Transmission Electron Microscopy

For each patient, fresh and vitrified/warmed samples were fixed in a 4% paraformaldehyde solution in distilled water maintained at pH 7.4 overnight at 4°C. After osmium tetroxide postfixation and alcohol dehydration, the samples were embedded in epoxy resin (Araldite M hardener, Fluka, Buchs, Switzerland) and then sectioned using an ultramicrotome (Ultracut, Reichert, Vienna, Austria). For each sample, one 0.5 μm thick section out of every 50 was collected and stained with toluidine blue. Sections were initially observed under a microscope (Nikon) at ×10 magnification to detect artifacts and discharge samples without cortical tissue. Sections were then observed at ×25 to establish the development stage of the follicle, according to Gougeon classification [15], and to evaluate architecture and nuclear and cytoplasm features of stromal cells. Finally, sections were analysed at ×40 to evaluate follicle and interstitial injury on at least 10 random microscopic high power fields (HPF) and scored using the method previously described by Fabbri et al. [5]. Semithin sections were viewed in a blind fashion by two different pathologists using a Leitz Diaplan light microscope equipped with a CCD JVC video camera, and digitized images were analyzed with Image ProPlus software.

After semithin sectioning, the 60 nm thick sections were collected on 200 mesh grids, stained with uranyl acetate followed by lead citrate and viewed using a Philips 410 T transmission electron microscope at 80 kV, in order to evaluate the ultrastructural features of follicles before and after vitrification/warming. Chromatin pattern, integrity of organelles, and membranes were carefully screened for oocytes, granulosa as well as stromal cells, according to previously reported subcellular criteria [5].

2.5. Apoptosis Analysis

For each patient, fresh and vitrified/warmed samples were fixed in 4% formaldehyde, embedded in paraffin, and serially sectioned at a thickness of 4 μm. Every 5 slides, one was stained with haematoxylin and eosin (Merck KGaA, Darmstadt, Germany) for histological evaluation; the other slides were TUNEL stained, for apoptosis evaluation (POD, Roche, Mannheim, Germany), according to the manufacturer’s instructions. Brown nuclei indicated TUNEL-positive cells. Follicles with more than two TUNEL-positive granulosa cells were considered to be apoptotic, as well as those follicles with TUNEL-positive oocytes. A total of 100 follicles were analyzed for each experimental condition. The number of apoptotic stromal cells was analyzed in a 100 μm2 square (randomly assigned in the sections) and was counted three times and then averaged. The percentage of apoptotic cells was calculated as follows: apoptotic cell number/total cell number × 100 and quantified in a double blind fashion using a Leitz Diaplan light microscope equipped with a CCD JVC video camera. Digitized images were analyzed with Image ProPlus software.

2.6. Statistical Analysis

For each variable (follicle damage and interstitial edema), at least 10 fields were scored on an integer scale of 0–3. Differences in the mean score among fresh and vitrified/warmed samples were statistically analyzed using Kruskal-Wallis test followed by Dunn multiple comparison test (GraphPad Prism version 4). The Student’s -test was used to analyze the percentage of apoptotic cells observed in fresh and vitrified/warmed samples (GraphPad Prism version 4). was considered statistically significant.

3. Results

3.1. Light and Transmission Electron Microscopy

A total of 1479 follicles (from fresh and vitrified/warmed samples) were analyzed by light microscopy to evaluate the morphology, the developmental stage, and the percentage of degenerated follicles on the total number of follicles (Table 1). The number of follicles was equally distributed among fresh and vitrified/warmed samples (53% versus 47%; ). The follicle density (follicle number per mm2 of the overall section area) was /mm2 in fresh and /mm2 in vitrified/warmed tissue (). Overall, 1429 follicles (96.5%) were primordial and intermediary, 43 (3%) primary, 5 (0.36%) secondary, 1 (0.07%) preantral, and 1 (0.07%) antral.


Samples
( )
Degenerated follicles/total number of follicles (%)
Primordial/intermediaryPrimarySecondaryPreantralAntralTOT.

t0 (29) (27) (50) (0%) (0%)757
t1 (32) (32) (33) (0%) (0%)722

t0: fresh tissue; t1: vitrified/warmed tissue.

In fresh samples follicles showed close adherence between oocyte and granulosa cells with normal morphological appearance: the oocytes had many mitochondria located around the nucleus, homogenous cytoplasm, and no vacuoles were observed. Stromal cells had oval- to spindle-shaped nucleus with a finely dispersed chromatin, small cytoplasm vacuoles were seen, and no interstitial edema was present (Figure 1(a)).

The vitrified samples showed oocyte nucleus with slightly thickened chromatin and irregular shape, while granulosa cells were well preserved. The architecture of the ovarian stromal was intact, maintaining the features of not vitrified tissue even though an increased cytoplasm vacuolization was observed (Figure 1(b)).

The data obtained by statistical analysis showed that no significant differences were observed in the overall preservation of ovarian tissue processed according to the vitrification protocol when compared with fresh tissue (Figure 2).

To extend and validate LM evaluation, ultrastructural analysis was performed. A total of 132 follicles, equally distributed among fresh and vitrified/warmed samples (70 versus 62, ), were analyzed. The fresh samples showed follicles containing large oocytes with regular nuclei, finely dispersed chromatin, nuclear pores, and abundant cytoplasm. Mitochondria appeared typically rounded, with a low-density matrix and few peripheral cristae, clustered in clouds or arranged in a rosette-like pattern around a dense, amorphous or finely granular intermitochondrial substance. Golgi apparatus was well developed; a few cisternae of rough endoplasmic reticulum were seen and occasional lipid inclusions and lipofuscin bodies as well. A close adhesion between oocyte and follicular cells was commonly seen. Granulosa cells showed flat nuclei with one or two reticular nucleoli. Rod-shaped mitochondria, free ribosomes, rough and smooth endoplasmic reticulum, and scattered vacuoles were observed in the cell cytoplasm (Figure 3(a)). The stroma showed spindle cell with moderately dispersed chromatin and homogeneous cytoplasm and slight signs of vacuolization (Figure 3(b)).

The vitrified/warmed follicles had nucleus with slight irregular shape and finely dispersed chromatin. Clear vacuoles were seen in the oocyte cytoplasm and a slight clarification of the cytoplasmic matrix as well. Cytoplasmic organelles were altered in shape and distribution. Irregularly shaped or swollen mitochondria were found scattered in the cytoplasm or around large vacuoles. Granulosa cells were adherent to oocyte (Figure 3(c)). Stromal cells showed moderately dispersed chromatin and homogeneous cytoplasm with slight vacuolization and enlarged mitochondria (Figure 3(d)).

3.2. TUNEL Assay

Only follicles with a visible oocyte nucleus were analyzed. The percentage of apoptotic follicles was 5% and 6% in fresh and vitrified/warmed samples, respectively (). The percentage of DNA damaged stromal cells evaluated in fresh and vitrified/warmed samples was 11% and 12%, respectively (; Figure 4).

4. Discussion

Today the cryopreservation of ovarian tissue before the start of cancer treatments is proposed as an option for preserving fertility. It allows recovering of a large number of follicles; it may be performed at any time of the menstrual cycle avoiding delay in the onset of antineoplastic therapy; it is particularly indicated in patients with hormone-related cancers, and it is the only option for prepubertal patients [3].

The critical points in the cryopreservation of ovarian tissue are determined by the presence of heterogeneous cellular components (oocytes, granulosa, and stromal cells) with different properties, which make the osmotic dehydration and rehydration extremely variable [16].

Cryopreservation strategies for ovarian tissue have therefore aimed to optimize methods and protocols for the preservation of whole tissue [13].

In the last decade there has been a great interest for the vitrification, since it might prevent tissue damage due to ice crystal formation. The success of vitrification depends on many factors such as sample size, type and concentration of cryoprotectants, temperature of exposure to vitrification solution, stepwise addition of vitrification solution, carrier system, quality of samples, and technical expertise [13].

Because of so many variables, the results obtained from vitrification are discrepant from species to species and within the same species [13].

The vitrification of ovarian tissue in animal models (mouse, sheep, ovine, bovine, monkey, hamster, rabbit, and baboon) has produced promising results: follicles maintain the same survival rates, morphology, and ultrastructure comparable to fresh follicles, yielding even live births in some species [3, 13].

In human, many studies support vitrification as the method of choice for ovarian tissue cryopreservation, providing similar results to conventional freezing, with the additional advantage of preserving the ultrastructure of stromal tissue that is usually affected by freezing [1, 2, 13, 1719]. However the live birth of babies from transplantation of vitrified ovarian tissue has not yet been obtained. Therefore, despite the encouraging results, absolute conclusions cannot easily be drawn.

In our study large size samples and two solutions were used to vitrify human ovarian tissue in an open system. In order to promote the dehydration of large size samples, a combination of ethylene glycol, propylene glycol, and sucrose at different concentrations and a long equilibration time were applied. Light and transmission electron microscopy and TUNEL analysis were applied to monitor the efficiency of our vitrification protocol.

The literature data show that the sample’s sizes have a strong influence on the preservation; in fact using small specimens with better results has been obtained [13]. However studies in sheep by Bordes group [20] obtained the birth of four lambs and the recovery of ovarian endocrine function by half ovary vitrification [20, 21]. In addition, data reported by Ferreira et al. [22] on bovine ovarian cortex showed that there was an increased risk of morphological damage to primary and primordial follicles when the tissue slices were cut with all dimension larger than 2 mm, provided that one of the dimensions of the fragment slice is maintained ≤2 mm [22]. The vitrification of large size samples of human ovarian tissue could be particularly useful, because the handling of the tissue and the gain in terms of follicular population are better using the larger samples [23].

Our results show that after vitrification/warming the stromal compartment maintains morphological and ultrastructural features similar to those seen in fresh tissue. Regarding follicles, the granulosa cells appear well preserved, while the oocyte appears slightly negatively affected by vitrification, as shown by increased cytoplasm vacuolization and organelle changes. These features might be considered as early signs of follicular degeneration, likely due to an inadequate dehydration and/or osmotic stress [24].

Our results are in agreement with those reported by other authors [2528]. Gandolfi et al. [25] showed that vitrification caused extensive morphological damage to primordial follicle in human ovarian tissue. Isachenko et al. [26] compared conventional freezing and vitrification of human ovarian tissue in terms of follicular quality, steroidogenic activity, and proliferative potential by GAPDH gene expression. The results provided evidence that conventional freezing allowed a better preservation of all types of follicles and a higher proliferative capacity of the tissue than vitrification, concluding that conventional freezing is the method of choice for the cryopreservation of human ovarian tissue. Irregularly shaped or swollen mitochondria scattered in the cytoplasm of both oocytes and follicular cells were reported by Zhou et al. [27] using conventional vitrification. Oktem et al. [28] reported that vitrified ovaries contained statistically significantly fewer primordial follicles and reported statistically significantly less hormonal production in vitro when compared with fresh and slow-frozen ovaries.

In the present study we also evaluated the frequency of apoptosis in ovarian tissue after vitrification. In agreement with previous studies, TUNEL assay does not show evidence of any statistical difference in apoptosis between fresh and vitrified samples [17, 18]. This finding suggests that the cryodamages induced by vitrification occur mainly in cytoplasmic organelles and cell membranes, preserving the nuclear compartment. In fact, at nuclear level the most likely consequence of vitrification would be the necrosis process, which can be better demonstrated using careful morphological and ultrastructural analysis [16].

Certainly a limitation of the present study has been the lack of functional tests that allowed determining if the damage done to oocytes was reversible and transitory or not. Further investigation such as xeno-transplantation might give information about viability of the follicle within the tissue. Nevertheless, tissue culture might be an excellent alternative method to demonstrate the viability of the tissue.

5. Conclusions

In conclusion, our vitrification protocol showed a good preservation of the stromal compartment, as also reported by other authors in the literature. This finding indicates that vitrification protocols are efficient for human ovarian tissue cryopreservation compared with conventional freezing, because stromal damages are avoided. However, in our study slight damages to the oocytes were observed after vitrification. Therefore, further studies are necessary and essential to optimize the vitrification protocol and to decide to switch from conventional freezing to vitrification for human ovarian tissue cryopreservation. The final proof to propose vitrification of ovarian tissue to patients will only be the birth of healthy babies after reimplantation of vitrified tissue.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

  1. H. J. Chang, J. H. Moon, J. R. Lee, B. C. Jee, C. S. Suh, and S. H. Kim, “Optimal condition of vitrification method for cryopreservation of human ovarian cortical tissues,” Journal of Obstetrics and Gynaecology Research, vol. 37, no. 8, pp. 1092–1101, 2011. View at: Publisher Site | Google Scholar
  2. C. A. Amorim, M. M. Dolmans, A. David et al., “Vitrification and xenografting of human ovarian tissue,” Fertility and Sterility, vol. 98, no. 5, pp. 1291.e2–1298.e2, 2012. View at: Publisher Site | Google Scholar
  3. J. Donnez, M. M. Dolmans, A. Pellicer et al., “Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation,” Fertility and Sterility, vol. 99, no. 6, pp. 1503–1513, 2013. View at: Publisher Site | Google Scholar
  4. L. H. Wang, S. F. Mullen, Y. Li, J. Q. Zhong, J. K. Crister, and Z. J. Chen, “Morphological and apoptotic comparison of primordial and primary follicles in cryopreserved human ovarian tissue,” Reproduction in Domestic Animals, vol. 44, no. 6, pp. 879–883, 2009. View at: Publisher Site | Google Scholar
  5. R. Fabbri, G. Pasquinelli, D. Keane, V. Magnani, R. Paradisi, and S. Venturoli, “Optimization of protocols for human ovarian tissue cryopreservation with sucrose, 1,2-propanediol and human serum,” Reproductive BioMedicine Online, vol. 21, no. 6, pp. 819–828, 2010. View at: Publisher Site | Google Scholar
  6. M. Salehnia, E. A. Moghadam, and M. R. Velojerdi, “Ultrastructure of follicles after vitrification of mouse ovarian tissue,” Fertility and Sterility, vol. 78, no. 3, pp. 644–645, 2002. View at: Publisher Site | Google Scholar
  7. F. Migishima, R. Suzuki-Migishima, S.-Y. Song et al., “Successful cryopreservation of mouse ovaries by vitrification,” Biology of Reproduction, vol. 68, no. 3, pp. 881–887, 2003. View at: Publisher Site | Google Scholar
  8. B. Courbiere, J. Massardier, B. Salle, C. Mazoyer, J.-F. Guerin, and J. Lornage, “Follicular viability and histological assessment after cryopreservation of whole sheep ovaries with vascular pedicle by vitrification,” Fertility and Sterility, vol. 84, no. 2, pp. 1065–1071, 2005. View at: Publisher Site | Google Scholar
  9. T. Ishijima, Y. Kobayashi, D.-S. Lee et al., “Cryopreservation of canine ovaries by vitrification,” The Journal of Reproduction and Development, vol. 52, no. 2, pp. 293–299, 2006. View at: Publisher Site | Google Scholar
  10. Q. Wang, S. Tian, Q. Wang, Q. Huang, and J. Yang, “Melting characteristics during the vitrification of MSWI fly ash with a pilot-scale diesel oil furnace,” Journal of Hazardous Materials, vol. 160, no. 2-3, pp. 376–381, 2008. View at: Publisher Site | Google Scholar
  11. A. Cobo, M. J. de los Santos, D. Castellò, P. Gámiz, P. Campos, and J. Remohí, “Outcomes of vitrified early cleavage-stage and blastocyst-stage embryos in a cryopreservation program: evaluation of 3, 150 warming cycles,” Fertility and Sterility, vol. 98, no. 5, pp. 1138.e1–1146.e1, 2012. View at: Publisher Site | Google Scholar
  12. L. L. Kuleshova and A. Lopata, “Vitrification can be more favorable than slow cooling,” Fertility and Sterility, vol. 78, no. 3, pp. 449–454, 2002. View at: Publisher Site | Google Scholar
  13. C. A. Amorim, M. Curaba, A. van Langendonckt, M.-M. Dolmans, and J. Donnez, “Vitrification as an alternative means of cryopreserving ovarian tissue,” Reproductive BioMedicine Online, vol. 23, no. 2, pp. 160–186, 2011. View at: Publisher Site | Google Scholar
  14. L. Parmegiani, A. Accorsi, G. E. Cognigni, S. Bernardi, E. Troilo, and M. Filicori, “Sterilization of liquid nitrogen with ultraviolet irradiation for safe vitrification of human oocytes or embryos,” Fertility and Sterility, vol. 94, no. 4, pp. 1525–1528, 2010. View at: Publisher Site | Google Scholar
  15. A. Gougeon, “Regulation of ovarian follicular development in primates: facts and hypotheses,” Endocrine Reviews, vol. 17, no. 2, pp. 121–155, 1996. View at: Publisher Site | Google Scholar
  16. M. Sheikhi, K. Hultenby, B. Niklasson, M. Lundqvist, and O. Hovatta, “Preservation of human ovarian follicles within tissue frozen by vitrification in a xeno-free closed system using only ethylene glycol as a permeating cryoprotectant,” Fertility and Sterility, vol. 100, no. 1, pp. 170.e2–177.e2, 2013. View at: Publisher Site | Google Scholar
  17. M. Salehnia, M. Sheikhi, S. Pourbeiranvand, and M. Lundqvist, “Apoptosis of human ovarian tissue is not increased by either vitrification or rapid cooling,” Reproductive BioMedicine Online, vol. 25, no. 5, pp. 492–499, 2012. View at: Publisher Site | Google Scholar
  18. S. Herraiz, E. Novella-Maestre, B. Rodríguez et al., “Improving ovarian tissue cryopreservation for oncologic patients: slow freezing versus vitrification, effect of different procedures and devices,” Fertility and Sterility, vol. 101, no. 3, pp. 775.e1–784.e1, 2014. View at: Publisher Site | Google Scholar
  19. M. Abdollahi, M. Salehnia, S. Salehpour, and N. Ghorbanmehr, “Human ovarian tissue vitrification/warming has minor effect on the expression of apoptosis-related genes,” Iranian Biomedical Journal, vol. 17, pp. 179–186, 2013. View at: Google Scholar
  20. A. Bordes, J. Lornage, B. Demirci et al., “Normal gestations and live births after orthotopic autograft of vitrified-warmed hemi-ovaries into ewes,” Human Reproduction, vol. 20, no. 10, pp. 2745–2748, 2005. View at: Publisher Site | Google Scholar
  21. B. Courbiere, L. Caquant, C. Mazoyer, M. Franck, J. Lornage, and B. Salle, “Difficulties improving ovarian functional recovery by microvascular transplantation and whole ovary vitrification,” Fertility and Sterility, vol. 91, no. 6, pp. 2697–2706, 2009. View at: Publisher Site | Google Scholar
  22. M. Ferreira, A. Bos-Mikich, N. Frantz, J. L. Rodrigues, A. L. Brunetto, and G. Schwartsmann, “The effects of sample size on the outcome of ovarian tissue cryopreservation,” Reproduction in Domestic Animals, vol. 45, no. 1, pp. 99–102, 2010. View at: Publisher Site | Google Scholar
  23. E. Jeremias, M. A. Bedaiwy, D. Nelson, C. V. Biscotti, and T. Falcone, “Assessment of tissue injury in cryopreserved ovarian tissue,” Fertility and Sterility, vol. 79, no. 3, pp. 651–653, 2003. View at: Publisher Site | Google Scholar
  24. A. Camboni, B. Martinez-Madrid, M.-M. Dolmans et al., “Preservation of fertility in young cancer patients: contribution of transmission electron microscopy,” Reproductive BioMedicine Online, vol. 17, no. 1, pp. 136–150, 2008. View at: Google Scholar
  25. F. Gandolfi, A. Paffoni, E. P. Brambilla, S. Bonetti, T. A. L. Brevini, and G. Ragni, “Efficiency of equilibrium cooling and vitrification procedures for the cryopreservation of ovarian tissue: comparative analysis between human and animal models,” Fertility and Sterility, vol. 85, no. 1, pp. 1150–1156, 2006. View at: Publisher Site | Google Scholar
  26. V. Isachenko, I. Lapidus, E. Isachenko et al., “Human ovarian tissue vitrification versus conventional freezing: morphological, endocrinological, and molecular biological evaluation,” Reproduction, vol. 138, no. 2, pp. 319–327, 2009. View at: Publisher Site | Google Scholar
  27. X.-H. Zhou, Y.-J. Wu, J. Shi, Y.-X. xia, and S.-S. Zheng, “Cryopreservation of human ovarian tissue: comparison of novel direct cover vitrification and conventional vitrification,” Cryobiology, vol. 60, no. 2, pp. 101–105, 2010. View at: Publisher Site | Google Scholar
  28. O. Oktem, E. Alper, B. Balaban et al., “Vitrified human ovaries have fewer primordial follicles and produce less antimüllerian hormone than slow-frozen ovaries,” Fertility and Sterility, vol. 95, no. 8, pp. 2661.e1–2664.e1, 2011. View at: Publisher Site | Google Scholar

Copyright © 2014 Raffaella Fabbri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1538 Views | 904 Downloads | 20 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.